| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |